Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-036823

Options or other derivatives

  • Director acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SIEGALL CLAY B · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-05-28 Grant or award : show line 1 in the form Director Stock Option (right to buy) +35,000 $27.90 2031-05-27 35,000 35,000 D
Loading xslF345X03/doc4.xml…